Partner
Tim Xiao
Partner, Delos Capital
- Firm
- Delos Capital
- Title
- Partner
- Role
- Partner
- Location
- Hong Kong
- Known as
- Investor
Claim, correct or request removal
Record updated 17 September 2026
About
Tim is a Partner and founding member at Delos Capital, with 16 years of experience in life science advisory and investments. Tim led the firm’s investments in and serves on the boards of Curatia Medical, Eccogene, LipoSeuticals, ReNiva, STRM.Bio, and Zenas. Tim is also a board observer for Allecra, Atia Vision, Rgenta, and Sirius. Tim previously served as a board member for Luqa Pharma (acq. by China Medical System) and Clover Biopharma (HKEx:2197), and as a board observer for Apama Medical (acq. by Boston Scientific). Prior to joining Delos Capital, Tim spent seven years in investment banking, most recently with Goldman Sachs.
Background
- Education
- Tim received his M.S. in Biotechnology from the Johns Hopkins University and his B.S. in Economics from Shanghai Jiao Tong University. He is also a CFA charter holder.Source (opens in a new tab)
Is this you? Remove my profile
Loading relationship preview